Summary
38 / 100 · Bulios Score
What speaks for it
- The price moves less than the market (beta 0.27).
What to watch
- The company made a loss over the last 12 months.
- Revenue growth is slowing: 8.3% a year over the last 3 years against 23% over 5 years.
- It missed profit estimates 4 times in the last 6 quarters.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 23% a year over 5 years. Over the last 3 years it grew by 8.3% a year.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Product 75%
- Advertising 14%
- Revenue Project 5.8%
- Software 4.6%
- Product and Service, Other 0.8%
- Other 0.2%
By region
The company reports no revenue by region.
Product brings in 75% of revenue.
Segments in detail